IBRX Stock Eyes Weekly Slump Despite Anktiva FDA Win — Retail Stays Cautious Ahead Of Founder’s Trial Talk
Founder Patrick Soon-Shiong has signaled a trial-status discussion at Friday’s Piper Sandler fireside chat. The FDA expanded approval for Anktiva, adding BCG-unresponsive papillary-only bladder cancer. The decision arrived about three months before the FDA …